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Edited by Horst FeldmannAbstract Silent information regulator 2 (Sir2) is an NAD+-
dependent histone deacetylase that establishes repressive chro-
matin status and extends the life span of both budding yeast
and the nematode worm Caenorhabditis elegans. There is grow-
ing evidence that its mammalian homologue Sir2a protects cells
from stress-induced apoptosis. We report here that mammalian
Sir2a was directly cleaved by both initiator and executioner
caspases, and relocated from the nucleus to the cytoplasm in
apoptotic cells. These alterations of Sir2a were largely inhibited
by a caspase-9 dominant-negative mutant or Bcl-xL. Our results
indicate that Sir2a undergoes dynamic changes in caspase-
dependent manner during apoptosis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The silent information regulator 2 (SIR2) family of genes is a
highly conserved group of genes present in the genomes of
organisms ranging from archaebacteria to eukaryotes. When
overexpressed, the encoded SIR2 protein extends the lifespan
of both budding yeast and the nematode worm Caenorhabditis
elegans. In the C. elegans, this extension of lifespan can be ob-
served in the presence of daf-16, which is the only C. elegans
homologue of the FOXO family of forkhead transcription fac-
tors [1]. Although the mechanisms underlying the increased lon-
gevity are still unclear, recent studies indicate that Sir2a can
promote stress resistance through anti-apoptotic eﬀects inmam-
malian cells. Mammalian Sir2a/SIRT1 deacetylates FOXO3
and/or FOXO4, thus attenuating FOXO-induced apoptosis
and potentiating FOXO-induced cell-cycle arrest [2,3]. In addi-
tion, increased Sir2a activity reduces p53-mediated apoptosis
and slows cellular senescence [4]. Since FOXO3 and p53 interact
with one another, speciﬁcally under conditions of oxidative
stress [2], Sir2a might increase cell viability by shifting the
FOXO- and/or p53-dependent response.
In this study, we found that Sir2a was directly cleaved by
caspases. In addition, Sir2a localized in the cytoplasm of dying
cells but not in the nucleus where Sir2a exist. A considerable
number of cells with cytoplasmic Sir2a had pyknotic nuclei in
Ara-C treated embryonic brain. These alterations were largely
inhibited by a dominant-negative form of caspase-9 (caspase-9*Corresponding author. Fax: +81 3 5841 4867.
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doi:10.1016/j.febslet.2006.09.051DN) or Bcl-xL in vitro, suggesting that caspase-dependent sig-
nals inﬂuence the status of Sir2a during apoptosis.2. Material and methods
2.1. Constructs
The vector encoding mouse Sir2a (Sir2a-pIRES-hrGFP-1a) was
kindly provided by Dr. Y. Horio [5]. Sir2a cDNA was tagged at the
N terminus with the Flag epitope and subcloned into the pcDNA3
expression vector (Flag-Sir2a-pcDNA3). Non-tagged Sir2a cDNA
was also subcloned into the pcDNA3.1() expression vector (Sir2a-
pcDNA3.1()). The vector encoding caspase-9 DN (caspase-9
C287S–Flag-pcDNA3) was kindly provided by Dr. T. Tsuruo [6].
The vector encoding human Bcl-xL (Bcl-xL-pCAX) was kindly pro-
vided by Dr. T. Iwawaki.
2.2. Tissue preparation for immunohistochemistry
C57BL/6 mice were used for the immunohistochemistry experiments
as previously described [7]. To induce apoptosis in neural precursor
cells, Ara-C at 250 mg/kg body weight was injected into pregnant mice
between gestational days 12 and 13 [8]. Embryos were isolated 6 h later
and immersed as described [7].
2.3. Immunoﬂuorescence staining
The staining method has been described [7]. The following antibod-
ies were used at the indicated dilutions: rabbit polyclonal anti-Sir2a (a
kind gift from Dr. Y. Horio; 1:5000), rabbit polyclonal active-caspase-
3 (AC3), generated as described [9] (1:1000) and mouse monoclonal
anti-Bcl-x (BD transduction laboratories; 1:500).
2.4. Cells, immunostaining, preparation of cell lysates, and
immunoblotting
HeLa cells were cultured in DMEM containing 10% fetal bovine ser-
um (FBS). The mouse neuroblastoma cell line Neuro 2a (N2a) cells
were cultured in DMEM containing 10% FBS and 2 mM L-glutamine.
After treatment with the apoptotic reagent, the cells were ﬁxed with 4%
paraformaldehyde in PB (PFA/PB) for immunostaining. For immuno-
blotting, cells were lysed in 2· SDS sample buﬀer (120 mM Tris–HCl
pH 6.8, 4% SDS, and 20% glycerol). The lysates were then separated
by 10% SDS–PAGE. The following antibodies were used at the indi-
cated dilutions for immunoblotting: rabbit polyclonal anti-Sir2a
(1:5000), rabbit polyclonal AC3 (1:1000), mouse monoclonal anti-Flag
M2 (Sigma 1:800) and mouse monoclonal b-tubulin (CHEMICON;
1:1000). A horseradish peroxidase-conjugated antibody (anti-rabbit
or anti-mouse IgG, Transduction Laboratories; 1:2000) was used as
the secondary antibody.
2.5. In vitro cleavage of Sir2a
The in vitro cleavage assay was performed as described previously
[10]. The Sir2a protein was prepared by in vitro transcription and
translation using a TNT-coupled reticulocyte lysate system (Promega)
and Flag-Sir2a-pcDNA3 as a template. Sir2a protein (2 ll) was incu-
bated at 37 C in 20 ll of reaction mixture with 1 U puriﬁed active-cas-
pase-1, -3, -6, -8, or -9 (MBL) for 4 h. The buﬀer for the reaction
mixture contained 20 mM HEPES (pH 7.5), 10 mM KCl, 1.5 mM
MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF,
2 lg/ml aprotinin, and 5 lg/ml pepstatin A.blished by Elsevier B.V. All rights reserved.
Fig. 1. Sir2a was cleaved in caspase-dependent manner. An anti-Sir2a polyclonal antibody or b-tubulin monoclonal antibody was used for western
blotting. (A) N2a cells were treated with either 250 nM staurosporine (STS) or 10 lM etoposide for the indicated time. (B) Both mock-transfected
cells and Sir2a-pIRES-hrGFP-1a transfected HeLa cells were either not treated or treated with 50 ng/ml TNF and 10 lg/ml CHX. zVAD-fmk
(100 lM) was added to the cells 2 h before the treatment with TNF/CHX. (C) N2a cells were transfected with Flag-Sir2a-pcDNA3 or in combination
with Bcl-xL-pCAX or caspase-9 DN-pcDNA3, and either not treated or treated with STS. zVAD-fmk (100 lM) was added to the cells 1 h before the
treatment with STS. (D) In vitro cleavage analysis of Sir2a. Sir2a synthesized in vitro was cleaved by puriﬁed activated caspase-1, -3, -6, -8, or -9 for
4 h. The reaction mixture was then subjected to Western blot analysis using the anti-Sir2a antibody.
Fig. 2. Sir2a was translocated from the nucleus to the cytoplasm in caspase-dependent manner. (A) Immunoﬂuorescence analysis of Sir2a using the
anti-Flag M2 antibody. HeLa cells were transfected with Flag-Sir2a-pcDNA3. After treatment with the indicated reagents, the cells were
immunostained with an anti-Flag antibody. (B) HeLa cells expressing Flag-Sir2a together with Venus, Bcl-xL, or caspase-9 dominant negative (DN)
were incubated in the presence of TNF/CHX for 3 h. Sir2a was visualized with an anti-Sir2a antibody or anti-Flag antibody. Bcl-xL and caspase-9
DN were visualized with an anti-Bcl-x antibody or anti-Flag antibody, respectively. The localization of Sir2a and the morphology of the nuclei in
Venus-, Bcl-xL-, or caspase-9 DN-expressing cells was examined. C, cytoplasm; N, nucleus.
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3.1. Cleavage of Sir2a by caspases during apoptosis
To investigate the state of Sir2a in dying cells, Neuro2a
(N2a) cells were treated with staurosporine (STS) or etoposide,Fig. 3. In animals treated with Ara-C, a considerable number of cells with cyt
zone of the embryonic brain. (A) Five-micrometer sections were stained
characterized by pyknotic nuclei and a cytoplasmic localization of Sir2a. (B
among 150 cytoplasmic Sir2a cells. Pyknosis (), pyknosis (+/), and pykno
respectively.which induce caspase-dependent cell death. Endogenous Sir2a
was cleaved in response to these apoptotic stimuli (Fig. 1A).
When exogenous Sir2a was expressed in HeLa cells and N2a
cells, the same cleavage patterns were observed (Fig. 1B and
C). In addition, both caspase-9 DN and Bcl-xL, which inhibitoplasmic Sir2a were characterized by pyknotic nuclei, in the ventricular
with anti-Sir2a and Hoechest 33342. Arrowheads show dying cells,
) The number of pyknotic (+), pyknotic (+/), or pyknotic () cells
sis (+) represent the intact, weakly, and strongly fragmented nucleus,
5878 S. Ohsawa, M. Miura / FEBS Letters 580 (2006) 5875–5879the apoptotic mitochondrial pathway [6,11,12], strongly inhib-
ited the cleavage of exogenous Sir2a in apoptotic N2a cells
(Fig. 1C). The pan-caspase inhibitor zVAD also suppressed
the cleavage of Sir2a in HeLa and N2a cells.
To examine further the possible involvement of caspases in
the cleavage of Sir2a, we digested recombinant Flag-Sir2a with
recombinant caspases in vitro. Sir2a was cleaved by caspase-1,
-3, -8 and -9, resulting in diﬀerent cleavage products (Fig. 1D).
The apparent molecular masses of the Sir2a fragments ob-
tained after in vitro cleavage by the caspases were similar to
those from cultured cells treated with apoptotic reagents. Band
‘‘a’’ was produced by initiator caspases, caspase-1, -8, and -9,
and by the executioner caspase, caspase-3. Band ‘‘b’’ was gen-
erated by caspase-3. Band ‘‘c’’ was generated by caspase-9, and
this band was preferentially reduced when apoptosis was inhib-
ited by caspase-9 DN or Bcl-xL, supporting the idea that band
‘‘c’’ was generated by caspase-9 activation in vivo. Thus, Sir2a
is a unique caspase substrate because it is cleaved by both ini-
tiator and executioner caspases. These data suggest that Sir2a
is directly regulated by multiple caspases throughout the apop-
totic process.
3.2. The change of Sir2a in subcellular localization from the
nucleus to the cytoplasm
We next investigated the localization of Sir2a. HeLa cells
were transfected with the Sir2a expression vector. Sir2a was
localized to the nucleus of cells in normal conditions
(Fig. 2A), consistent with previous reports [4,5,13]. However,
in response to TNF-a, Sir2-a was observed in the cytoplasm
of dying cells. Both caspase-9 DN and Bcl-xL resulted in Sir2a
remaining in the nucleus (Fig. 2B). These data suggest that
Sir2a changes the localization from the nucleus to the cyto-
plasm in a caspase-dependent manner.
Furthermore, we examined the staining patterns of the anti-
Sir2a antibody in vivo. We induced apoptosis in neural precur-
sor cells of embryonic mice with a cytidine analogue, Ara-C,
which is known to induce neural precursor cell death in the
embryo [8]. We found that Sir2a was dominantly localized to
the nucleus of normal cells, but in a part of cells, Sir2a was
localized to the cytoplasm (Fig. 3A). Of 150 cells with cyto-
plasmic Sir2a, over 130 had pyknotic nuclei (Fig. 3B), suggest-
ing that cytoplasmic localization of Sir2a correlated with
apoptotic process.4. Discussion
The ﬁndings presented here show that one of the histone
deacetylases, Sir2a, was cleaved by caspases and released from
the nucleus to the cytoplasm during caspase-dependent apop-
tosis. Since Sir2a was cleaved by multiple caspases, including
caspase-9 and -3, its cleavage and dislocation must take place
throughout the apoptotic process.
In response to damage or stress, cells attempt to repair and
defend themselves, but if unsuccessful, they often undergo pro-
grammed cell death, or apoptosis. In mammals, it is becoming
increasingly apparent that Sir2a is a key regulator of cell de-
fenses and survival in response to stress. SIRT1/Sir2a-deﬁcient
cells are sensitive to pro-apoptotic stimuli, including ionizing
radiation, staurosporine, and oxidative stress [14]. Overexpres-
sion of Sir2a or treatment with a Sir2a agonist, resveratrol,
inhibits Amyloid-b induced neuronal death [15]. Resveratrolalso rescues neuronal cells from mutant polyglutamine cyto-
toxicity [16]. While these studies focused on the protective ef-
fect of Sir2a during cell stress, our data are the ﬁrst to show
the dynamics of Sir2a in cells fated to die.
Apoptotic cell death is accompanied by degradation of chro-
mosomal DNA. However, early in the apoptotic process,
eukaryotic DNA is still tightly wrapped around histones. Pre-
vious study showed that Sir2a is involved in a modiﬁcation of
histones that in turn leads to the transcriptional inactivation of
chromosome domains, by packaging them into a condensed
chromatin structure [17,18]. Caspase-mediated cleavage of
Sir2a may facilitate to loose chromatin structure that allows
caspase-dependent DNase (CAD) to access DNA.
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